{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:12:22Z","timestamp":1770819142287,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Herzzentrum G\u00f6ttingen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Research into treatment options that complement surgery for open spinal dysraphism (OSD) is necessary to further improve outcomes following prenatal or postnatal surgery. We investigated erythropoietin (Epo) and its receptor (EpoR) as a potential neuroprotective agent and target in OSD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Epo- and EpoR-expression was examined on mRNA and immunohistochemical level in neuroplacodes obtained from a rat retinoic acid-induced OSD model at E16, E18, E22. Neural progenitor cells (NPCs) derived from spinal cords of adult Long Evans rats were exposed to varying concentrations of human artificial amniotic fluid (aAF). Cytotoxicity assays were conducted to assess the impact of aAF exposure, with and without Epo. The influence of Epo on NPC\u2019s cellular marker expression was analyzed using qRT-PCR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>EpoR mRNA expression was elevated significantly on E18 and E22 in OSD- compared to control tissue. EpoR immunoreactivity exhibited consistent expression in ventral and dorsal horns, central canal, and ganglia. It co-stained with Hif-2\u03b1, \u03b2-III-tubulin, NeuN, and Musashi1. Exposure of NPCs to aAF reduced proliferation and increased death rates dose-dependently. Adding Epo significantly counteracted antiproliferative and cytotoxic aAF effects on NPCs, resulting in similar or lower death rates than those observed in untreated controls. Exposure of NPCs to aAF reduced their expression of neuronal markers. Adding Epo restored their differentiation capacities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Induction of EpoR in neuroplacodes, its co-staining with neuronal and NPC markers, and the neuroprotective effects of Epo on aAF-treated NPCs in vitro establish Epo as a promising candidate for neuroprotective therapies that can supplement surgical measures for OSD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00381-025-07032-8","type":"journal-article","created":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T23:57:32Z","timestamp":1763337452000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuroprotective properties of erythropoietin (Epo) and its receptor (EpoR) in open spinal dysraphism (OSD): an investigation of EpoR expression in a rat OSD model, along with in vitro studies on the neuroprotective effects of Epo on rat spinal cord-derived neural progenitor cells"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4907-015X","authenticated-orcid":false,"given":"Friederike","family":"Knerlich-Lukoschus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Cl\u00fcver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inez","family":"Manczuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frieda","family":"Bayler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Hellmold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Synowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janka","family":"Held-Feindt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"7032_CR1","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1227\/00006123-199006000-00011","volume":"26","author":"DS Heffez","year":"1990","unstructured":"Heffez DS, Aryanpur J, Hutchins GM, Freeman JM (1990) The paralysis associated with myelomeningocele: clinical and experimental data implicating a preventable spinal cord injury. Neurosurgery 26:987\u2013992","journal-title":"Neurosurgery"},{"key":"7032_CR2","first-page":"213","volume":"106","author":"D Stiefel","year":"2007","unstructured":"Stiefel D, Copp AJ, Meuli M (2007) Fetal spina bifida in a mouse model: loss of neural function in utero. J Neurosurg 106:213\u2013221","journal-title":"J Neurosurg"},{"key":"7032_CR3","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/486758","volume":"2015","author":"F Knerlich-Lukoschus","year":"2015","unstructured":"Knerlich-Lukoschus F, Held-Feindt J (2015) Chemokine-ligands\/receptors: multiplayers in traumatic spinal cord injury. Mediators Inflamm 2015:486758","journal-title":"Mediators Inflamm"},{"key":"7032_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.neulet.2016.12.004","volume":"652","author":"BJ Hilton","year":"2017","unstructured":"Hilton BJ, Moulson AJ, Tetzlaff W (2017) Neuroprotection and secondary damage following spinal cord injury: concepts and methods. Neurosci Lett 652:3\u201310","journal-title":"Neurosci Lett"},{"key":"7032_CR5","doi-asserted-by":"publisher","first-page":"562","DOI":"10.4103\/1673-5374.155423","volume":"10","author":"F Knerlich-Lukoschus","year":"2015","unstructured":"Knerlich-Lukoschus F (2015) Chemokines and their receptors: important mediators to be aware of in neuroregenerative approaches for spinal cord injury. Neural Regen Res 10:562\u2013564","journal-title":"Neural Regen Res"},{"key":"7032_CR6","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1007\/s11064-021-03242-z","volume":"46","author":"S Hemani","year":"2021","unstructured":"Hemani S, Lane O, Agarwal S, Yu SP, Woodbury A (2021) Systematic review of erythropoietin (EPO) for neuroprotection in human studies. Neurochem Res 46:732\u2013739","journal-title":"Neurochem Res"},{"key":"7032_CR7","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1177\/1535370214523703","volume":"239","author":"AQ Nguyen","year":"2014","unstructured":"Nguyen AQ, Cherry BH, Scott GF, Ryou MG, Mallet RT (2014) Erythropoietin: powerful protection of ischemic and post-ischemic brain. Exp Biol Med (Maywood) 239:1461\u20131475","journal-title":"Exp Biol Med (Maywood)"},{"key":"7032_CR8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1542\/peds.2007-2711","volume":"122","author":"SE Juul","year":"2008","unstructured":"Juul SE, McPherson RJ, Bauer LA, Ledbetter KJ, Gleason CA, Mayock DE (2008) A phase I\/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety. Pediatrics 122:383\u2013391","journal-title":"Pediatrics"},{"key":"7032_CR9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.pediatrneurol.2014.06.008","volume":"51","author":"V Rangarajan","year":"2014","unstructured":"Rangarajan V, Juul SE (2014) Erythropoietin: emerging role of erythropoietin in neonatal neuroprotection. Pediatr Neurol 51:481\u2013488","journal-title":"Pediatr Neurol"},{"key":"7032_CR10","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.pediatrneurol.2014.08.010","volume":"51","author":"EE Rogers","year":"2014","unstructured":"Rogers EE, Bonifacio SL, Glass HC, Juul SE, Chang T, Mayock DE, Durand DJ, Song D, Barkovich AJ, Ballard RA, Wu YW (2014) Erythropoietin and hypothermia for hypoxic-ischemic encephalopathy. Pediatr Neurol 51:657\u2013662","journal-title":"Pediatr Neurol"},{"key":"7032_CR11","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1542\/peds.2012-0498","volume":"130","author":"YW Wu","year":"2012","unstructured":"Wu YW, Bauer LA, Ballard RA, Ferriero DM, Glidden DV, Mayock DE, Chang T, Durand DJ, Song D, Bonifacio SL, Gonzalez FF, Glass HC, Juul SE (2012) Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics. Pediatrics 130:683\u2013691","journal-title":"Pediatrics"},{"key":"7032_CR12","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1089\/neu.2017.4981","volume":"35","author":"G Cohrs","year":"2018","unstructured":"Cohrs G, Goerden S, Lucius R, Synowitz M, Mehdorn HM, Held-Feindt J, Knerlich-Lukoschus F (2018) Spatial and cellular expression patterns of erythropoietin-receptor and erythropoietin during a 42-day post-lesional time course after graded thoracic spinal cord impact lesions in the rat. J Neurotrauma 35:593\u2013607","journal-title":"J Neurotrauma"},{"key":"7032_CR13","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.expneurol.2005.03.011","volume":"194","author":"E Danzer","year":"2005","unstructured":"Danzer E, Schwarz U, Wehrli S, Radu A, Adzick NS, Flake AW (2005) Retinoic acid induced myelomeningocele in fetal rats: characterization by histopathological analysis and magnetic resonance imaging. Exp Neurol 194:467\u2013475","journal-title":"Exp Neurol"},{"key":"7032_CR14","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1089\/neu.2021.0091","volume":"38","author":"G Cohrs","year":"2021","unstructured":"Cohrs G, Blumenrother AK, Surie JP, Synowitz M, Held-Feindt J, Knerlich-Lukoschus F (2021) Fetal and perinatal expression profiles of proinflammatory cytokines in the neuroplacodes of rats with myelomeningoceles: a contribution to the understanding of secondary spinal cord injury in open spinal dysraphism. J Neurotrauma 38:3376\u20133392","journal-title":"J Neurotrauma"},{"key":"7032_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00381-018-3984-6","volume":"35","author":"G Cohrs","year":"2019","unstructured":"Cohrs G, Drucks B, Surie JP, Vokuhl C, Synowitz M, Held-Feindt J, Knerlich-Lukoschus F (2019) Expression profiles of pro-inflammatory and pro-apoptotic mediators in secondary tethered cord syndrome after myelomeningocele repair surgery. Childs Nerv Syst 35:315\u2013328","journal-title":"Childs Nerv Syst"},{"key":"7032_CR16","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/jnen\/nlw057","volume":"75","author":"B Kowitzke","year":"2016","unstructured":"Kowitzke B, Cohrs G, Leuschner I, Koch A, Synowitz M, Mehdorn HM, Held-Feindt J, Knerlich-Lukoschus F (2016) Cellular profiles and molecular mediators of lesion cascades in the placode in human open spinal neural tube defects. J Neuropathol Exp Neurol 75:827\u2013842","journal-title":"J Neuropathol Exp Neurol"},{"key":"7032_CR17","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/jnr.23527","volume":"93","author":"F Knerlich-Lukoschus","year":"2015","unstructured":"Knerlich-Lukoschus F, Krossa S, Krause J, Mehdorn HM, Scheidig A, Held-Feindt J (2015) Impact of chemokines on the properties of spinal cord-derived neural progenitor cells in a rat spinal cord lesion model. J Neurosci Res 93:562\u2013571","journal-title":"J Neurosci Res"},{"key":"7032_CR18","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/0002-9378(74)90093-3","volume":"119","author":"RJ Benzie","year":"1974","unstructured":"Benzie RJ, Doran TA, Harkins JL, Owen VM, Porter CJ (1974) Composition of the amniotic fluid and maternal serum in pregnancy. Am J Obstet Gynecol 119:798\u2013810","journal-title":"Am J Obstet Gynecol"},{"key":"7032_CR19","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1471-0528.1969.tb05874.x","volume":"76","author":"PN Gillibrand","year":"1969","unstructured":"Gillibrand PN (1969) Changes in amniotic fluid volume with advancing pregnancy. J Obstet Gynaecol Br Commonw 76:527\u2013529","journal-title":"J Obstet Gynaecol Br Commonw"},{"key":"7032_CR20","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/ansa.202100055","volume":"3","author":"D Naila","year":"2022","unstructured":"Naila D, Sadanand S, Sussman D (2022) Artificial amniotic fluid for nuclear magnetic resonance spectroscopy studies. Anal Sci Adv 3:174\u2013187","journal-title":"Anal Sci Adv"},{"key":"7032_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1590\/S0100-879X2002000200010","volume":"35","author":"FR Oliveira","year":"2002","unstructured":"Oliveira FR, Barros EG, Magalh\u00e3es JA (2002) Biochemical profile of amniotic fluid for the assessment of fetal and renal development. Braz J Med Biol Res 35:215\u2013222","journal-title":"Braz J Med Biol Res"},{"key":"7032_CR22","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/j.1471-0528.1979.tb10826.x","volume":"86","author":"BR Pettit","year":"1979","unstructured":"Pettit BR, Baker SP, King GS (1979) The composition of amniotic fluid in pregnancies complicated by fetal anencephaly or spina bifida. Br J Obstet Gynaecol 86:637\u2013641","journal-title":"Br J Obstet Gynaecol"},{"key":"7032_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12868-023-00789-1","volume":"24","author":"T Niemann","year":"2023","unstructured":"Niemann T, Greiner JFW, Kaltschmidt C, Kaltschmidt B (2023) EPO regulates neuronal differentiation of adult human neural-crest derived stem cells in a sex-specific manner. BMC Neurosci 24:19","journal-title":"BMC Neurosci"},{"key":"7032_CR24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.brainres.2010.01.040","volume":"1321","author":"B Sims","year":"2010","unstructured":"Sims B, Clarke M, Njah W, Hopkins ES, Sontheimer H (2010) Erythropoietin-induced neuroprotection requires cystine glutamate exchanger activity. Brain Res 1321:88\u201395","journal-title":"Brain Res"},{"key":"7032_CR25","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.neuroscience.2010.02.007","volume":"167","author":"Y Wang","year":"2010","unstructured":"Wang Y, Yao M, Zhou C, Dong D, Jiang Y, Wei G, Cui X (2010) Erythropoietin promotes spinal cord-derived neural progenitor cell proliferation by regulating cell cycle. Neuroscience 167:750\u2013757","journal-title":"Neuroscience"},{"key":"7032_CR26","first-page":"264","volume":"17","author":"H Zhang","year":"2018","unstructured":"Zhang H, Fang X, Huang D, Luo Q, Zheng M, Wang K, Cao L, Yin Z (2018) Erythropoietin signaling increases neurogenesis and oligodendrogenesis of endogenous neural stem cells following spinal cord injury both in vivo and in vitro. Mol Med Rep 17:264\u2013272","journal-title":"Mol Med Rep"},{"key":"7032_CR27","doi-asserted-by":"publisher","DOI":"10.1088\/1748-605X\/acccc4","author":"D Hellmold","year":"2023","unstructured":"Hellmold D, Arnaldi P, Synowitz M, Held-Feindt J, Akbari M (2023) A biopolymeric mesh enriched with PLGA microparticles loaded with AT101 for localized glioblastoma treatment. Biomed Mater. https:\/\/doi.org\/10.1088\/1748-605X\/acccc4","journal-title":"Biomed Mater"},{"key":"7032_CR28","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/glia.20974","volume":"58","author":"F Knerlich-Lukoschus","year":"2010","unstructured":"Knerlich-Lukoschus F, von der Ropp-Brenner B, Lucius R, Mehdorn HM, Held-Feindt J (2010) Chemokine expression in the white matter spinal cord precursor niche after force-defined spinal cord contusion injuries in adult rats. Glia 58:916\u2013931","journal-title":"Glia"},{"key":"7032_CR29","doi-asserted-by":"publisher","first-page":"9471","DOI":"10.1523\/JNEUROSCI.2838-06.2006","volume":"26","author":"JC Chavez","year":"2006","unstructured":"Chavez JC, Baranova O, Lin J, Pichiule P (2006) The transcriptional activator hypoxia inducible factor 2 (HIF-2\/EPAS-1) regulates the oxygen-dependent expression of erythropoietin in cortical astrocytes. J Neurosci 26:9471\u20139481","journal-title":"J Neurosci"},{"key":"7032_CR30","doi-asserted-by":"publisher","first-page":"9848","DOI":"10.1073\/pnas.0901840106","volume":"106","author":"PE Sanchez","year":"2009","unstructured":"Sanchez PE, Fares RP, Risso JJ, Bonnet C, Bouvard S, Le-Cavorsin M, Georges B, Moulin C, Belmeguenai A, Bodennec J, Morales A, Pequignot JM, Baulieu EE, Levine RA, Bezin L (2009) Optimal neuroprotection by erythropoietin requires elevated expression of its receptor in neurons. Proc Natl Acad Sci U S A 106:9848\u20139853","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7032_CR31","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1002\/pd.6681","volume":"44","author":"Y Athiel","year":"2024","unstructured":"Athiel Y, Jouannic JM, L\u00e9pine M, Maillet C, de Saint DT, Larghero J, Guilbaud L (2024) Role of amniotic fluid toxicity in the pathophysiology of myelomeningocele: a narrative literature review. Prenat Diagn 44:1530\u20131535","journal-title":"Prenat Diagn"},{"key":"7032_CR32","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1159\/000121250","volume":"27","author":"MJ Drewek","year":"1997","unstructured":"Drewek MJ, Bruner JP, Whetsell WO, Tulipan N (1997) Quantitative analysis of the toxicity of human amniotic fluid to cultured rat spinal cord. Pediatr Neurosurg 27:190\u2013193","journal-title":"Pediatr Neurosurg"},{"key":"7032_CR33","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1159\/000055964","volume":"33","author":"M Olguner","year":"2000","unstructured":"Olguner M, Akg\u00fcr FM, Ozdemir T, Aktu\u011f T, Ozer E (2000) Amniotic fluid exchange for the prevention of neural tissue damage in myelomeningocele: an alternative minimally invasive method to open in utero surgery. Pediatr Neurosurg 33:252\u2013256","journal-title":"Pediatr Neurosurg"},{"key":"7032_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-019-1667-y","volume":"9","author":"W Si","year":"2019","unstructured":"Si W, Wang J, Li M, Qu H, Gu R, Liu R, Wang L, Li S, Hu X (2019) Erythropoietin protects neurons from apoptosis via activating PI3K\/AKT and inhibiting Erk1\/2 signaling pathway. 3 Biotech 9:131","journal-title":"3 Biotech"},{"key":"7032_CR35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/bdra.23466","volume":"106","author":"L Avagliano","year":"2016","unstructured":"Avagliano L, Doi P, Tosi D, Scagliotti V, Gualtieri A, Gaston-Massuet C, Pistocchi A, Gallina A, Marconi AM, Bulfamante G, Massa V (2016) Cell death and cell proliferation in human spina bifida. Birth Defects Res A Clin Mol Teratol 106:104\u2013113","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"7032_CR36","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3171\/PED\/2008\/2\/8\/150","volume":"2","author":"JL Reis","year":"2008","unstructured":"Reis JL, Correia-Pinto J, Monteiro MP, Costa M, Hutchins GM (2008) Vascular and apoptotic changes in the placode of myelomeningocele mice during the final stages of in utero development. J Neurosurg Pediatr 2:150\u2013157","journal-title":"J Neurosurg Pediatr"},{"key":"7032_CR37","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/med.20184","volume":"31","author":"A Murua","year":"2011","unstructured":"Murua A, Orive G, Hern\u00e1ndez RM, Pedraz JL (2011) Emerging technologies in the delivery of erythropoietin for therapeutics. Med Res Rev 31:284\u2013309","journal-title":"Med Res Rev"},{"key":"7032_CR38","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1016\/j.ijbiomac.2021.11.065","volume":"193","author":"XY Wu","year":"2021","unstructured":"Wu XY, Zhu YM, Qi Y, Xu WW, Jing Z (2021) Erythropoietin, as a biological macromolecule in modification of tissue engineered constructs: a review. Int J Biol Macromol 193:2332\u20132342","journal-title":"Int J Biol Macromol"},{"key":"7032_CR39","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s40199-021-00399-4","volume":"29","author":"M Gholami","year":"2021","unstructured":"Gholami M, Gilanpour H, Sadeghinezhad J, Asghari A (2021) Facile fabrication of an erythropoietin-alginate\/chitosan hydrogel and evaluation of its local therapeutic effects on spinal cord injury in rats. Daru 29:255\u2013265","journal-title":"Daru"},{"key":"7032_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/gels9110907","author":"R Ji","year":"2023","unstructured":"Ji R, Hao Z, Wang H, Li X, Duan L, Guan F, Ma S (2023) Application of injectable hydrogels as delivery systems in spinal cord injury. Gels. https:\/\/doi.org\/10.3390\/gels9110907","journal-title":"Gels"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-025-07032-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00381-025-07032-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-025-07032-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:18:30Z","timestamp":1770815910000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00381-025-07032-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["7032"],"URL":"https:\/\/doi.org\/10.1007\/s00381-025-07032-8","relation":{},"ISSN":["0256-7040","1433-0350"],"issn-type":[{"value":"0256-7040","type":"print"},{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"358"}}